Tai Chi Training for Persons With Multiple Sclerosis.
What it found
No result yet.
What was tested
Treatment tested
- Tai Chi training
What it measured
Main measures
MSIS-29
From enrollment to the end of treatment at 12 weeks
Quality of life (reported by participants)
Who could take part
Relapsing MS · 18 and over
Inclusion Criteria: * over 18 years age * definite MS diagnosis * ability to walk more than 100 m * no relapse or pharmacological treatment adjustment in the preceding eight weeks * no Tai Chi practice in the preceding six months * ability to understand and communicate in Swedish or English Exclusion Criteria: * dementia * alcoholism * serious medical comorbidity preventing participation
As registered. Criteria can change, so ask the trial team or your neurologist.
About this trial
In the sponsor's words
Tai Chi combines strength and neuromuscular training with diaphragmatic breathing, attention, imagery and relaxation. After an initial learning period, participants can practise independently, potentially supporting self-efficacy and sustained self-management. Studies in chronic disease report benefits for physical function and psychological wellbeing. The investigators will evaluate a 12-week Tai Chi rehabilitation programme in a clincial trial. The Multiple Sclerosis Impact Scale (MSIS-29) is the primary clinical outcome, reflecting the physical and psychological consequences of multiple sclerosis (MS). Assessments take place before training and at 12 weeks (the primary endpoint). The study will address whether Tai Chi improves physical and mental health; reduces fatigue, anxiety, depression and pain; improves lower-limb strength, gait and balance; and improves quality of life and self-efficacy.
Loading reviews and guidelines…
History
Started
Mar 2025
Main results due
Dec 2027
Finished
Mar 2028
Assembled by software from public sources and not checked by people. Each record links to its source. Report an error